Citizens Financial Group Inc Biomarin Pharmaceutical Inc Transaction History

Citizens Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $6,108 - $11,137	-85 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$71.37 - $96.85 $5,852 - $7,941	-82 Reduced 49.1%	85 $7,000
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $7,391 - $9,932	115 Added 221.15%	167 $14,000
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $4,178 - $4,882	52 New	52 $4,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.